StonvexLoading…
StonvexStonvexStonvexCore line items from WHR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.52B | $16.61B | $19.45B | $19.72B |
Operating Income | $838.00M | $143.00M | $1.01B | $-1.06B |
Net Income | $318.00M | $-323.00M | $481.00M | $-1.52B |
EPS (Diluted) | $5.66 | $-5.87 | $8.72 | $-27.18 |
Total Assets | $16.00B | $16.30B | $17.31B | $17.12B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $669.00M | $1.27B | $1.57B | $1.96B |
Free Cash Flow OCF − CapEx | $81.00M | $384.00M | $366.00M | $820.00M |
Shares Outstanding | 56.00M | 55.00M | 55.00M | 54.00M |